Eligo Bioscience Funding: $54M Raised, Series B (2023)
Eligo Bioscience is based in Paris, France. It has raised $54M in total funding. Latest round: Series B.
Eligo Bioscience funding overview
Eligo Bioscience is based in Paris, France. Eligo Bioscience has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2023. The round record for Eligo Bioscience runs through 2023; nothing later has been disclosed. Investors on record include Khosla Ventures, Seventure Partners, Sanofi Ventures, Bpifrance (InnoBio), Fusion Fund. 5 distinct backers are named across the disclosed rounds.
Eligo Bioscience at a glance
Total raised
$54M
Latest round
Series B
Latest round date
December 2023
Headquarters
Paris, France
Notable investors
Khosla Ventures, Seventure Partners, Sanofi Ventures, Bpifrance (InnoBio), Fusion Fund
Frequently asked about Eligo Bioscience funding
How much has Eligo Bioscience raised?
Eligo Bioscience has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Eligo Bioscience?
Khosla Ventures, Seventure Partners, Sanofi Ventures, Bpifrance (InnoBio), Fusion Fund are named among the investors backing Eligo Bioscience.
What was the latest Eligo Bioscience funding round?
The most recent disclosed round is a Series B, announced in December 2023.
Where is Eligo Bioscience based?
Eligo Bioscience is based in Paris, France.
When did Eligo Bioscience last raise?
The last disclosed Eligo Bioscience round closed in December 2023 at Series B.
Round data for Eligo Bioscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Paris and backer lists below.
